Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Hospital Clinic of Barcelona |
---|---|
Information provided by: | Hospital Clinic of Barcelona |
ClinicalTrials.gov Identifier: | NCT00787774 |
Prospective study to evaluate the potential persistent viral effect of raltegravir in 20 treatment experienced HIV patients with incomplete viral suppression
Condition | Intervention |
---|---|
HIV Infection |
Drug: resume raltegravir |
Study Type: | Interventional |
Study Design: | Screening, Open Label, Uncontrolled, Single Group Assignment |
Official Title: | Integrase Resistance Analysis in Treated Experienced HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression |
Estimated Enrollment: | 20 |
Study Start Date: | November 2008 |
Estimated Study Completion Date: | January 2010 |
Estimated Primary Completion Date: | January 2010 (Final data collection date for primary outcome measure) |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Subject has any currently active AIDS defining illness (Category C conditions according to the CDC Classification System for HIV Infection 1993) with the following 2 exceptions:
Contact: Jose Luis Blanco, MD | +34932275400 ext 3311 |
Spain | |
Hospital Clinic | Recruiting |
Barcelona, Spain, 08036 | |
Principal Investigator: Jose Luis Blanco, MD |
Study Chair: | Jose M Gatell, MD | Hospital Clinic Barcelona |
Responsible Party: | Hospital Clínic ( José Luis Blanco Arévalo ) |
Study ID Numbers: | RAL-dyn |
Study First Received: | November 7, 2008 |
Last Updated: | November 7, 2008 |
ClinicalTrials.gov Identifier: | NCT00787774 |
Health Authority: | Spain: Ethics Committee |
HIV resistance integrase |
Virus Diseases Sexually Transmitted Diseases, Viral HIV Infections Sexually Transmitted Diseases |
Acquired Immunodeficiency Syndrome Retroviridae Infections Immunologic Deficiency Syndromes |
RNA Virus Infections Slow Virus Diseases Immune System Diseases Lentivirus Infections Infection |